Ontology type: schema:ScholarlyArticle Open Access: True
2011-12-19
AUTHORSJennifer M Kress-Bennett, Garth D Ehrlich, Ashley Bruno, J Christopher Post, Fen Z Hu, Thomas F Scott
ABSTRACTBackgroundThere are a lack of biomarkers which can be used to predict clinical outcomes for multiple sclerosis (MS) patients receiving interferon beta (IFN-β). Thus the objective of this study was to characterize changes in CD4+ T-lymphocyte expression in an unbiased manner following initiation of intramuscular (IM) IFN-β-1a treatment, and then to verify those findings using marker-specific assays.MethodsPeripheral blood specimens were collected from twenty MS patients before and after treatment with intramuscular (IM) IFN-β-1a and were used for isolation of mononuclear cells (PBMCs). mRNA expression patterns of negatively-selected CD4+ T-cells from the PBMCs were analyzed using microarray gene expression technology. IL-12 and IL-23 receptor levels on PBMC-derived CD4+ T-cells were analyzed by flow cytometry. The phosphorylation status of Stat4 was measured by performing densitometry on western blots.ResultsMicroarray analyses demonstrated that mRNA expression of the IL-12Rβ2 gene was uniformly up-regulated in response to IFN-β-1a treatment and was associated with an increased number of IL-12Rβ2+ CD4+ T-cells by flow cytometry in 4 of 6 patients. This finding was substantiated by demonstrating that Stat4 phosphorylation, a transcription factor for IL-12, was increased after treatment. Conversely, the number of IL-23R+ CD4+ T-cells was decreased following treatment.ConclusionsThe IL-12 receptor shares a common subunit, the IL-12Rβ2, with the IL-23 receptor. Both of these receptors have a probable role in regulating IL-17 and TH-17 cells, important mediators of inflammation in multiple sclerosis (MS). Thus, the changes in the numbers of CD4+ T-cells expressing these receptors in response to IFN-β-1a treatment may point to an important mechanism of action for this drug, but further large scale studies are needed to confirm these preliminary observations. More... »
PAGES155
http://scigraph.springernature.com/pub.10.1186/1471-2377-11-155
DOIhttp://dx.doi.org/10.1186/1471-2377-11-155
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1043445460
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/22182694
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Immunology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adjuvants, Immunologic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "CD4 Lymphocyte Count",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "CD4-Positive T-Lymphocytes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Injections, Intramuscular",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Interferon beta-1a",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Interferon-beta",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Interleukin-12 Receptor beta 2 Subunit",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lymphocyte Activation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multiple Sclerosis, Relapsing-Remitting",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Interleukin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Interleukin-12",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.280673.8",
"name": [
"Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Kress-Bennett",
"givenName": "Jennifer M",
"id": "sg:person.01277343354.29",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277343354.29"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.166341.7",
"name": [
"Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Microbiology and Immunology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Ehrlich",
"givenName": "Garth D",
"id": "sg:person.01324252605.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324252605.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.413621.3",
"name": [
"Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Bruno",
"givenName": "Ashley",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.166341.7",
"name": [
"Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Microbiology and Immunology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Post",
"givenName": "J Christopher",
"id": "sg:person.01055120221.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055120221.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.166341.7",
"name": [
"Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Microbiology and Immunology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Hu",
"givenName": "Fen Z",
"id": "sg:person.010625263442.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010625263442.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA",
"id": "http://www.grid.ac/institutes/grid.166341.7",
"name": [
"Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA",
"Department of Neurology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Scott",
"givenName": "Thomas F",
"id": "sg:person.01162716033.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162716033.14"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/nm.2110",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053047527",
"https://doi.org/10.1038/nm.2110"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ni0407-345",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024255218",
"https://doi.org/10.1038/ni0407-345"
],
"type": "CreativeWork"
}
],
"datePublished": "2011-12-19",
"datePublishedReg": "2011-12-19",
"description": "BackgroundThere are a lack of biomarkers which can be used to predict clinical outcomes for multiple sclerosis (MS) patients receiving interferon beta (IFN-\u03b2). Thus the objective of this study was to characterize changes in CD4+ T-lymphocyte expression in an unbiased manner following initiation of intramuscular (IM) IFN-\u03b2-1a treatment, and then to verify those findings using marker-specific assays.MethodsPeripheral blood specimens were collected from twenty MS patients before and after treatment with intramuscular (IM) IFN-\u03b2-1a and were used for isolation of mononuclear cells (PBMCs). mRNA expression patterns of negatively-selected CD4+ T-cells from the PBMCs were analyzed using microarray gene expression technology. IL-12 and IL-23 receptor levels on PBMC-derived CD4+ T-cells were analyzed by flow cytometry. The phosphorylation status of Stat4 was measured by performing densitometry on western blots.ResultsMicroarray analyses demonstrated that mRNA expression of the IL-12R\u03b22 gene was uniformly up-regulated in response to IFN-\u03b2-1a treatment and was associated with an increased number of IL-12R\u03b22+ CD4+ T-cells by flow cytometry in 4 of 6 patients. This finding was substantiated by demonstrating that Stat4 phosphorylation, a transcription factor for IL-12, was increased after treatment. Conversely, the number of IL-23R+ CD4+ T-cells was decreased following treatment.ConclusionsThe IL-12 receptor shares a common subunit, the IL-12R\u03b22, with the IL-23 receptor. Both of these receptors have a probable role in regulating IL-17 and TH-17 cells, important mediators of inflammation in multiple sclerosis (MS). Thus, the changes in the numbers of CD4+ T-cells expressing these receptors in response to IFN-\u03b2-1a treatment may point to an important mechanism of action for this drug, but further large scale studies are needed to confirm these preliminary observations.",
"genre": "article",
"id": "sg:pub.10.1186/1471-2377-11-155",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1024950",
"issn": [
"1471-2377"
],
"name": "BMC Neurology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "11"
}
],
"keywords": [
"IFN-\u03b2-1a treatment",
"T cells",
"multiple sclerosis",
"IL-12R\u03b22",
"IL-12",
"intramuscular IFN-\u03b2-1a",
"flow cytometry",
"IL-12R\u03b22 gene",
"Th-17 cells",
"number of CD4",
"IL-23 receptor",
"multiple sclerosis patients",
"T-lymphocyte expression",
"number of IL",
"lack of biomarkers",
"IFN \u03b2-1a",
"IL-17",
"MS patients",
"clinical outcomes",
"sclerosis patients",
"mononuclear cells",
"interferon beta",
"receptor levels",
"T lymphocytes",
"CD4",
"blood specimens",
"ResultsMicroarray analysis",
"mRNA expression",
"Western blot",
"important mediator",
"patients",
"large-scale studies",
"mRNA expression patterns",
"receptor shares",
"receptors",
"treatment",
"sclerosis",
"cytometry",
"probable role",
"preliminary observations",
"expression patterns",
"important mechanism",
"phosphorylation status",
"cells",
"PBMC",
"inflammation",
"transcription factors",
"common subunit",
"expression",
"BackgroundThere",
"findings",
"levels",
"biomarkers",
"STAT4",
"response",
"drugs",
"scale studies",
"outcomes",
"blot",
"mediators",
"IL",
"study",
"gene expression technology",
"densitometry",
"microarray gene expression technology",
"beta",
"status",
"assays",
"expression technology",
"changes",
"initiation",
"phosphorylation",
"unbiased manner",
"number",
"factors",
"genes",
"role",
"action",
"specimens",
"lack",
"objective",
"manner",
"subunits",
"mechanism",
"isolation",
"patterns",
"analysis",
"results",
"observations",
"technology",
"share"
],
"name": "Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12R\u03b22+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis",
"pagination": "155",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1043445460"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/1471-2377-11-155"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"22182694"
]
}
],
"sameAs": [
"https://doi.org/10.1186/1471-2377-11-155",
"https://app.dimensions.ai/details/publication/pub.1043445460"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:59",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_552.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/1471-2377-11-155"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2377-11-155'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2377-11-155'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2377-11-155'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2377-11-155'
This table displays all metadata directly associated to this object as RDF triples.
272 TRIPLES
21 PREDICATES
135 URIs
125 LITERALS
24 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/1471-2377-11-155 | schema:about | N04ef72cb0b3d4ff9a0f9c72e7e4dab5d |
2 | ″ | ″ | N0836d0b0d0fe408bb7161252aef04744 |
3 | ″ | ″ | N1023822824ab43b780028c75a3965625 |
4 | ″ | ″ | N123c582606ac4a5883b975d849065af6 |
5 | ″ | ″ | N1c27259af5544c9aa179599f8ce3dc3f |
6 | ″ | ″ | N442b7cac4b104de498c97cc13507c5f2 |
7 | ″ | ″ | N505658a0d7144a02969b8784b51c81e1 |
8 | ″ | ″ | N8adc36c6991b4ba5bb704a6bd77106f4 |
9 | ″ | ″ | Na760395c96ac4dad9e0242047f6501da |
10 | ″ | ″ | Nc054d8db46da4301951e7dc4c4ccf8b2 |
11 | ″ | ″ | Ndba3c226a61347c382e95e544719e309 |
12 | ″ | ″ | Nddc6ce4e1e1543969de1e2bd91f61172 |
13 | ″ | ″ | Nde75ad3a5fc240308a3d2836b874aa28 |
14 | ″ | ″ | Ne7b6c77ab9ee480fb3035e2d6f0991e2 |
15 | ″ | ″ | Neab4a95ea1fe48a3a49067c2d1965f48 |
16 | ″ | ″ | Nf5b8e7dd71fc4899a2e052ae3dbd769a |
17 | ″ | ″ | Nfe2c235280584a45b8d4f3e5dcfaef17 |
18 | ″ | ″ | anzsrc-for:11 |
19 | ″ | ″ | anzsrc-for:1107 |
20 | ″ | schema:author | N23dcd765d15641a28976e98dc1220408 |
21 | ″ | schema:citation | sg:pub.10.1038/ni0407-345 |
22 | ″ | ″ | sg:pub.10.1038/nm.2110 |
23 | ″ | schema:datePublished | 2011-12-19 |
24 | ″ | schema:datePublishedReg | 2011-12-19 |
25 | ″ | schema:description | BackgroundThere are a lack of biomarkers which can be used to predict clinical outcomes for multiple sclerosis (MS) patients receiving interferon beta (IFN-β). Thus the objective of this study was to characterize changes in CD4+ T-lymphocyte expression in an unbiased manner following initiation of intramuscular (IM) IFN-β-1a treatment, and then to verify those findings using marker-specific assays.MethodsPeripheral blood specimens were collected from twenty MS patients before and after treatment with intramuscular (IM) IFN-β-1a and were used for isolation of mononuclear cells (PBMCs). mRNA expression patterns of negatively-selected CD4+ T-cells from the PBMCs were analyzed using microarray gene expression technology. IL-12 and IL-23 receptor levels on PBMC-derived CD4+ T-cells were analyzed by flow cytometry. The phosphorylation status of Stat4 was measured by performing densitometry on western blots.ResultsMicroarray analyses demonstrated that mRNA expression of the IL-12Rβ2 gene was uniformly up-regulated in response to IFN-β-1a treatment and was associated with an increased number of IL-12Rβ2+ CD4+ T-cells by flow cytometry in 4 of 6 patients. This finding was substantiated by demonstrating that Stat4 phosphorylation, a transcription factor for IL-12, was increased after treatment. Conversely, the number of IL-23R+ CD4+ T-cells was decreased following treatment.ConclusionsThe IL-12 receptor shares a common subunit, the IL-12Rβ2, with the IL-23 receptor. Both of these receptors have a probable role in regulating IL-17 and TH-17 cells, important mediators of inflammation in multiple sclerosis (MS). Thus, the changes in the numbers of CD4+ T-cells expressing these receptors in response to IFN-β-1a treatment may point to an important mechanism of action for this drug, but further large scale studies are needed to confirm these preliminary observations. |
26 | ″ | schema:genre | article |
27 | ″ | schema:isAccessibleForFree | true |
28 | ″ | schema:isPartOf | N268ef85829a8412ea7d804ebe0d021c9 |
29 | ″ | ″ | N65e450347a804dcfbb09dc82d95a07b1 |
30 | ″ | ″ | sg:journal.1024950 |
31 | ″ | schema:keywords | BackgroundThere |
32 | ″ | ″ | CD4 |
33 | ″ | ″ | IFN β-1a |
34 | ″ | ″ | IFN-β-1a treatment |
35 | ″ | ″ | IL |
36 | ″ | ″ | IL-12 |
37 | ″ | ″ | IL-12Rβ2 |
38 | ″ | ″ | IL-12Rβ2 gene |
39 | ″ | ″ | IL-17 |
40 | ″ | ″ | IL-23 receptor |
41 | ″ | ″ | MS patients |
42 | ″ | ″ | PBMC |
43 | ″ | ″ | ResultsMicroarray analysis |
44 | ″ | ″ | STAT4 |
45 | ″ | ″ | T cells |
46 | ″ | ″ | T lymphocytes |
47 | ″ | ″ | T-lymphocyte expression |
48 | ″ | ″ | Th-17 cells |
49 | ″ | ″ | Western blot |
50 | ″ | ″ | action |
51 | ″ | ″ | analysis |
52 | ″ | ″ | assays |
53 | ″ | ″ | beta |
54 | ″ | ″ | biomarkers |
55 | ″ | ″ | blood specimens |
56 | ″ | ″ | blot |
57 | ″ | ″ | cells |
58 | ″ | ″ | changes |
59 | ″ | ″ | clinical outcomes |
60 | ″ | ″ | common subunit |
61 | ″ | ″ | cytometry |
62 | ″ | ″ | densitometry |
63 | ″ | ″ | drugs |
64 | ″ | ″ | expression |
65 | ″ | ″ | expression patterns |
66 | ″ | ″ | expression technology |
67 | ″ | ″ | factors |
68 | ″ | ″ | findings |
69 | ″ | ″ | flow cytometry |
70 | ″ | ″ | gene expression technology |
71 | ″ | ″ | genes |
72 | ″ | ″ | important mechanism |
73 | ″ | ″ | important mediator |
74 | ″ | ″ | inflammation |
75 | ″ | ″ | initiation |
76 | ″ | ″ | interferon beta |
77 | ″ | ″ | intramuscular IFN-β-1a |
78 | ″ | ″ | isolation |
79 | ″ | ″ | lack |
80 | ″ | ″ | lack of biomarkers |
81 | ″ | ″ | large-scale studies |
82 | ″ | ″ | levels |
83 | ″ | ″ | mRNA expression |
84 | ″ | ″ | mRNA expression patterns |
85 | ″ | ″ | manner |
86 | ″ | ″ | mechanism |
87 | ″ | ″ | mediators |
88 | ″ | ″ | microarray gene expression technology |
89 | ″ | ″ | mononuclear cells |
90 | ″ | ″ | multiple sclerosis |
91 | ″ | ″ | multiple sclerosis patients |
92 | ″ | ″ | number |
93 | ″ | ″ | number of CD4 |
94 | ″ | ″ | number of IL |
95 | ″ | ″ | objective |
96 | ″ | ″ | observations |
97 | ″ | ″ | outcomes |
98 | ″ | ″ | patients |
99 | ″ | ″ | patterns |
100 | ″ | ″ | phosphorylation |
101 | ″ | ″ | phosphorylation status |
102 | ″ | ″ | preliminary observations |
103 | ″ | ″ | probable role |
104 | ″ | ″ | receptor levels |
105 | ″ | ″ | receptor shares |
106 | ″ | ″ | receptors |
107 | ″ | ″ | response |
108 | ″ | ″ | results |
109 | ″ | ″ | role |
110 | ″ | ″ | scale studies |
111 | ″ | ″ | sclerosis |
112 | ″ | ″ | sclerosis patients |
113 | ″ | ″ | share |
114 | ″ | ″ | specimens |
115 | ″ | ″ | status |
116 | ″ | ″ | study |
117 | ″ | ″ | subunits |
118 | ″ | ″ | technology |
119 | ″ | ″ | transcription factors |
120 | ″ | ″ | treatment |
121 | ″ | ″ | unbiased manner |
122 | ″ | schema:name | Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis |
123 | ″ | schema:pagination | 155 |
124 | ″ | schema:productId | N25741cfa8f9f43faabaf3217c90199ab |
125 | ″ | ″ | N58bbf09c6f6e4f96bcaa4d040f72d738 |
126 | ″ | ″ | Nc051506584564d109d357b3a8996c199 |
127 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1043445460 |
128 | ″ | ″ | https://doi.org/10.1186/1471-2377-11-155 |
129 | ″ | schema:sdDatePublished | 2022-08-04T16:59 |
130 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
131 | ″ | schema:sdPublisher | N2f20f34a836d474bb454a017fb878a3d |
132 | ″ | schema:url | https://doi.org/10.1186/1471-2377-11-155 |
133 | ″ | sgo:license | sg:explorer/license/ |
134 | ″ | sgo:sdDataset | articles |
135 | ″ | rdf:type | schema:ScholarlyArticle |
136 | N04ef72cb0b3d4ff9a0f9c72e7e4dab5d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
137 | ″ | schema:name | CD4 Lymphocyte Count |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | N0836d0b0d0fe408bb7161252aef04744 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
140 | ″ | schema:name | Injections, Intramuscular |
141 | ″ | rdf:type | schema:DefinedTerm |
142 | N1023822824ab43b780028c75a3965625 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
143 | ″ | schema:name | Middle Aged |
144 | ″ | rdf:type | schema:DefinedTerm |
145 | N123c582606ac4a5883b975d849065af6 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
146 | ″ | schema:name | Interferon beta-1a |
147 | ″ | rdf:type | schema:DefinedTerm |
148 | N1c27259af5544c9aa179599f8ce3dc3f | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
149 | ″ | schema:name | Adjuvants, Immunologic |
150 | ″ | rdf:type | schema:DefinedTerm |
151 | N23dcd765d15641a28976e98dc1220408 | rdf:first | sg:person.01277343354.29 |
152 | ″ | rdf:rest | Nab0255c4c7bb48c587f071de1867de0a |
153 | N25741cfa8f9f43faabaf3217c90199ab | schema:name | dimensions_id |
154 | ″ | schema:value | pub.1043445460 |
155 | ″ | rdf:type | schema:PropertyValue |
156 | N268ef85829a8412ea7d804ebe0d021c9 | schema:issueNumber | 1 |
157 | ″ | rdf:type | schema:PublicationIssue |
158 | N2f20f34a836d474bb454a017fb878a3d | schema:name | Springer Nature - SN SciGraph project |
159 | ″ | rdf:type | schema:Organization |
160 | N442b7cac4b104de498c97cc13507c5f2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
161 | ″ | schema:name | Interleukin-12 Receptor beta 2 Subunit |
162 | ″ | rdf:type | schema:DefinedTerm |
163 | N505658a0d7144a02969b8784b51c81e1 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
164 | ″ | schema:name | Male |
165 | ″ | rdf:type | schema:DefinedTerm |
166 | N58bbf09c6f6e4f96bcaa4d040f72d738 | schema:name | doi |
167 | ″ | schema:value | 10.1186/1471-2377-11-155 |
168 | ″ | rdf:type | schema:PropertyValue |
169 | N65e450347a804dcfbb09dc82d95a07b1 | schema:volumeNumber | 11 |
170 | ″ | rdf:type | schema:PublicationVolume |
171 | N8adc36c6991b4ba5bb704a6bd77106f4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
172 | ″ | schema:name | Interferon-beta |
173 | ″ | rdf:type | schema:DefinedTerm |
174 | N8b0a842c67494415a8f77d48dbcc02ff | rdf:first | sg:person.010625263442.13 |
175 | ″ | rdf:rest | Nc862dbcb3b8444e296b818a757cc21e5 |
176 | Na760395c96ac4dad9e0242047f6501da | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
177 | ″ | schema:name | Female |
178 | ″ | rdf:type | schema:DefinedTerm |
179 | Na7facd6e140b41e9b0bd89604b1a4d1b | rdf:first | sg:person.01055120221.02 |
180 | ″ | rdf:rest | N8b0a842c67494415a8f77d48dbcc02ff |
181 | Naa331492bfcc468ca01d1550b0a8ed39 | schema:affiliation | grid-institutes:grid.413621.3 |
182 | ″ | schema:familyName | Bruno |
183 | ″ | schema:givenName | Ashley |
184 | ″ | rdf:type | schema:Person |
185 | Nab0255c4c7bb48c587f071de1867de0a | rdf:first | sg:person.01324252605.57 |
186 | ″ | rdf:rest | Nad4f095537de47fcbbe7d9e201dc6d69 |
187 | Nad4f095537de47fcbbe7d9e201dc6d69 | rdf:first | Naa331492bfcc468ca01d1550b0a8ed39 |
188 | ″ | rdf:rest | Na7facd6e140b41e9b0bd89604b1a4d1b |
189 | Nc051506584564d109d357b3a8996c199 | schema:name | pubmed_id |
190 | ″ | schema:value | 22182694 |
191 | ″ | rdf:type | schema:PropertyValue |
192 | Nc054d8db46da4301951e7dc4c4ccf8b2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
193 | ″ | schema:name | Receptors, Interleukin-12 |
194 | ″ | rdf:type | schema:DefinedTerm |
195 | Nc862dbcb3b8444e296b818a757cc21e5 | rdf:first | sg:person.01162716033.14 |
196 | ″ | rdf:rest | rdf:nil |
197 | Ndba3c226a61347c382e95e544719e309 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
198 | ″ | schema:name | Humans |
199 | ″ | rdf:type | schema:DefinedTerm |
200 | Nddc6ce4e1e1543969de1e2bd91f61172 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
201 | ″ | schema:name | Adult |
202 | ″ | rdf:type | schema:DefinedTerm |
203 | Nde75ad3a5fc240308a3d2836b874aa28 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
204 | ″ | schema:name | CD4-Positive T-Lymphocytes |
205 | ″ | rdf:type | schema:DefinedTerm |
206 | Ne7b6c77ab9ee480fb3035e2d6f0991e2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
207 | ″ | schema:name | Gene Expression |
208 | ″ | rdf:type | schema:DefinedTerm |
209 | Neab4a95ea1fe48a3a49067c2d1965f48 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
210 | ″ | schema:name | Lymphocyte Activation |
211 | ″ | rdf:type | schema:DefinedTerm |
212 | Nf5b8e7dd71fc4899a2e052ae3dbd769a | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
213 | ″ | schema:name | Multiple Sclerosis, Relapsing-Remitting |
214 | ″ | rdf:type | schema:DefinedTerm |
215 | Nfe2c235280584a45b8d4f3e5dcfaef17 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
216 | ″ | schema:name | Receptors, Interleukin |
217 | ″ | rdf:type | schema:DefinedTerm |
218 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
219 | ″ | schema:name | Medical and Health Sciences |
220 | ″ | rdf:type | schema:DefinedTerm |
221 | anzsrc-for:1107 | schema:inDefinedTermSet | anzsrc-for: |
222 | ″ | schema:name | Immunology |
223 | ″ | rdf:type | schema:DefinedTerm |
224 | sg:journal.1024950 | schema:issn | 1471-2377 |
225 | ″ | schema:name | BMC Neurology |
226 | ″ | schema:publisher | Springer Nature |
227 | ″ | rdf:type | schema:Periodical |
228 | sg:person.01055120221.02 | schema:affiliation | grid-institutes:grid.166341.7 |
229 | ″ | schema:familyName | Post |
230 | ″ | schema:givenName | J Christopher |
231 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055120221.02 |
232 | ″ | rdf:type | schema:Person |
233 | sg:person.010625263442.13 | schema:affiliation | grid-institutes:grid.166341.7 |
234 | ″ | schema:familyName | Hu |
235 | ″ | schema:givenName | Fen Z |
236 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010625263442.13 |
237 | ″ | rdf:type | schema:Person |
238 | sg:person.01162716033.14 | schema:affiliation | grid-institutes:grid.166341.7 |
239 | ″ | schema:familyName | Scott |
240 | ″ | schema:givenName | Thomas F |
241 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162716033.14 |
242 | ″ | rdf:type | schema:Person |
243 | sg:person.01277343354.29 | schema:affiliation | grid-institutes:grid.280673.8 |
244 | ″ | schema:familyName | Kress-Bennett |
245 | ″ | schema:givenName | Jennifer M |
246 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277343354.29 |
247 | ″ | rdf:type | schema:Person |
248 | sg:person.01324252605.57 | schema:affiliation | grid-institutes:grid.166341.7 |
249 | ″ | schema:familyName | Ehrlich |
250 | ″ | schema:givenName | Garth D |
251 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324252605.57 |
252 | ″ | rdf:type | schema:Person |
253 | sg:pub.10.1038/ni0407-345 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1024255218 |
254 | ″ | ″ | https://doi.org/10.1038/ni0407-345 |
255 | ″ | rdf:type | schema:CreativeWork |
256 | sg:pub.10.1038/nm.2110 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1053047527 |
257 | ″ | ″ | https://doi.org/10.1038/nm.2110 |
258 | ″ | rdf:type | schema:CreativeWork |
259 | grid-institutes:grid.166341.7 | schema:alternateName | Department of Neurology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
260 | ″ | ″ | Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
261 | ″ | schema:name | Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
262 | ″ | ″ | Department of Microbiology and Immunology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
263 | ″ | ″ | Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA |
264 | ″ | ″ | Department of Neurology, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
265 | ″ | ″ | Department of Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Allegheny Campus, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
266 | ″ | rdf:type | schema:Organization |
267 | grid-institutes:grid.280673.8 | schema:alternateName | Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
268 | ″ | schema:name | Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, 15212, Pittsburgh, PA, USA |
269 | ″ | rdf:type | schema:Organization |
270 | grid-institutes:grid.413621.3 | schema:alternateName | Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA |
271 | ″ | schema:name | Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, 15212, Pittsburgh, PA, USA |
272 | ″ | rdf:type | schema:Organization |